Sanders Morris Harris LLC Red Hill Biopharma Ltd. Transaction History

Sanders Morris Harris LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 09, 2020	SELL	$4.6 - $8.6 $295,168 - $551,836	-64,167 Closed	0 $0
Q1 2020 Apr 09, 2020	BUY	$3.51 - $6.17 $57,939 - $101,848	16,507 Added 34.63%	64,167 $289,000
Q4 2019 Jan 09, 2020	SELL	$5.76 - $7.35 $19,238 - $24,549	-3,340 Reduced 6.55%	47,660 $289,000
Q2 2019 Jul 10, 2019	BUY	$6.34 - $8.8 $323,340 - $448,800	51,000 New	51,000 $330,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $377M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Sanders Morris Harris LLC, based on Form 13F filings with the SEC.

Stay updated on Sanders Morris Harris LLC with notifications on news.